Anyang Tumor Hosptial

Anyang 455000

0 studies enrolling now · 2 studies all time

What they study most

Esophageal Squamous Cell Carcinoma, Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer

Studies at this site

• A Study of Atezolizumab With or Without Tiragolumab in Participants With Unresectable Esophageal Squamous Cell Carcinoma Whose Cancers Have Not Progressed Following Definitive Concurrent Chemoradiotherapy — Running, not enrolling
• A Study Evaluating the Efficacy and Safety of Giredestrant Combined With Palbociclib Compared With Letrozole Combined With Palbociclib in Participants With Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer (persevERA Breast Cancer) — Running, not enrolling